Skip to main content
editorial
. 2017 Jul 1;3(3):168–184. doi: 10.1016/S2055-6640(20)30338-1
A. High risk – recommend prescribing daily PrEP if the patient acknowledges
Having in the last 3 months
  • Shared injecting equipment with an HIV+ individual or with a gay or bisexual man of unknown HIV status

AND Being likely to have in the next 3 months (indicating sustained risk)
  • Multiple events of sharing injecting equipment with an HIV+ individual or a gay or bisexual man of unknown HIV status

  • Inadequate access to safe injecting equipment

Case-by-case approach
Based on a complete sexual and alcohol and other drug-using history and the personal circumstances of the patient, if the clinician is of the opinion that the patient is likely to be at high risk of HIV, then PrEP prescription may be considered despite the absence of reported high- or medium-risk factors above.